鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/26 | 3,790 | 3,880 | 3,760 | 3,855 | +65 | +1.7% | 48,200 |
| 2024/04/25 | 3,785 | 3,830 | 3,765 | 3,790 | +30 | +0.8% | 39,500 |
| 2024/04/24 | 3,820 | 3,820 | 3,730 | 3,760 | -20 | -0.5% | 18,900 |
| 2024/04/23 | 3,800 | 3,805 | 3,755 | 3,780 | +15 | +0.4% | 14,900 |
| 2024/04/22 | 3,745 | 3,780 | 3,705 | 3,765 | +75 | +2% | 20,100 |
| 2024/04/19 | 3,765 | 3,765 | 3,645 | 3,690 | -85 | -2.3% | 22,300 |
| 2024/04/18 | 3,695 | 3,790 | 3,650 | 3,775 | +110 | +3% | 44,900 |
| 2024/04/17 | 3,780 | 3,780 | 3,655 | 3,665 | -125 | -3.3% | 40,000 |
| 2024/04/16 | 3,860 | 3,875 | 3,785 | 3,790 | -105 | -2.7% | 26,500 |
| 2024/04/15 | 3,910 | 3,935 | 3,870 | 3,895 | -55 | -1.4% | 26,400 |
| 2024/04/12 | 3,975 | 3,990 | 3,950 | 3,950 | -25 | -0.6% | 15,600 |
| 2024/04/11 | 3,990 | 4,000 | 3,935 | 3,975 | -55 | -1.4% | 32,500 |
| 2024/04/10 | 4,010 | 4,040 | 4,010 | 4,030 | +20 | +0.5% | 5,200 |
| 2024/04/09 | 4,065 | 4,065 | 3,995 | 4,010 | -40 | -1% | 18,700 |
| 2024/04/08 | 4,070 | 4,075 | 4,010 | 4,050 | +20 | +0.5% | 14,800 |
| 2024/04/05 | 4,000 | 4,050 | 3,990 | 4,030 | +5 | +0.1% | 17,900 |
| 2024/04/04 | 4,070 | 4,080 | 4,005 | 4,025 | -85 | -2.1% | 34,100 |
| 2024/04/03 | 4,045 | 4,130 | 4,030 | 4,110 | +45 | +1.1% | 57,600 |
| 2024/04/02 | 4,140 | 4,140 | 4,020 | 4,065 | -45 | -1.1% | 41,100 |
| 2024/04/01 | 4,140 | 4,160 | 4,090 | 4,110 | +15 | +0.4% | 28,000 |
| 2024/03/29 | 4,115 | 4,115 | 4,060 | 4,095 | -20 | -0.5% | 16,400 |
| 2024/03/28 | 4,125 | 4,175 | 4,080 | 4,115 | -20 | -0.5% | 20,600 |
| 2024/03/27 | 4,050 | 4,155 | 4,050 | 4,135 | +135 | +3.4% | 35,700 |
| 2024/03/26 | 3,990 | 4,035 | 3,990 | 4,000 | -10 | -0.2% | 13,700 |
| 2024/03/25 | 3,990 | 4,040 | 3,950 | 4,010 | ±0 | ±0% | 38,700 |
| 2024/03/22 | 4,075 | 4,075 | 3,995 | 4,010 | -70 | -1.7% | 44,100 |
| 2024/03/21 | 4,140 | 4,170 | 4,070 | 4,080 | -55 | -1.3% | 29,700 |
| 2024/03/19 | 4,210 | 4,210 | 4,100 | 4,135 | -75 | -1.8% | 21,300 |
| 2024/03/18 | 4,235 | 4,285 | 4,210 | 4,210 | -20 | -0.5% | 21,800 |
| 2024/03/15 | 4,245 | 4,270 | 4,215 | 4,230 | -30 | -0.7% | 16,300 |
| 2024/03/14 | 4,295 | 4,295 | 4,195 | 4,260 | -5 | -0.1% | 16,400 |
| 2024/03/13 | 4,285 | 4,290 | 4,215 | 4,265 | -15 | -0.4% | 11,300 |
| 2024/03/12 | 4,315 | 4,315 | 4,205 | 4,280 | -35 | -0.8% | 21,500 |
| 2024/03/11 | 4,300 | 4,315 | 4,255 | 4,315 | -5 | -0.1% | 21,100 |
| 2024/03/08 | 4,220 | 4,370 | 4,220 | 4,320 | +55 | +1.3% | 39,300 |
| 2024/03/07 | 4,290 | 4,310 | 4,235 | 4,265 | -10 | -0.2% | 17,500 |
| 2024/03/06 | 4,225 | 4,300 | 4,215 | 4,275 | +95 | +2.3% | 30,500 |
| 2024/03/05 | 4,160 | 4,195 | 4,080 | 4,180 | ±0 | ±0% | 22,800 |
| 2024/03/04 | 4,210 | 4,260 | 4,170 | 4,180 | -15 | -0.4% | 28,600 |
| 2024/03/01 | 4,300 | 4,305 | 4,180 | 4,195 | -65 | -1.5% | 40,500 |
| 2024/02/29 | 4,220 | 4,285 | 4,205 | 4,260 | +60 | +1.4% | 36,200 |
| 2024/02/28 | 4,300 | 4,330 | 4,200 | 4,200 | -5 | -0.1% | 60,300 |
| 2024/02/27 | 4,150 | 4,215 | 4,135 | 4,205 | +90 | +2.2% | 37,000 |
| 2024/02/26 | 4,050 | 4,130 | 4,050 | 4,115 | +95 | +2.4% | 34,400 |
| 2024/02/22 | 4,030 | 4,050 | 4,005 | 4,020 | -10 | -0.2% | 22,900 |
| 2024/02/21 | 4,040 | 4,085 | 3,995 | 4,030 | -10 | -0.2% | 31,600 |
| 2024/02/20 | 4,040 | 4,070 | 4,025 | 4,040 | +10 | +0.2% | 20,900 |
| 2024/02/19 | 4,025 | 4,040 | 3,955 | 4,030 | -40 | -1% | 37,400 |
| 2024/02/16 | 3,965 | 4,090 | 3,945 | 4,070 | +170 | +4.4% | 76,100 |
| 2024/02/15 | 3,895 | 3,900 | 3,850 | 3,900 | +5 | +0.1% | 34,300 |
1～
50
件表示中 / 3445件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 385,500円 | +7.3% | +16.8% | 3.11% | 23.06倍 | 0.90倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
| 杏林製薬 | 182,800円 | +2.6% | +11.5% | 2.84% | 21.43倍 | 0.83倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 持田薬 | 314,500円 | -1.2% | -37.3% | 2.54% | 25.34倍 | 0.88倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 205,900円 | +6.8% | +18.7% | 2.14% | 12.97倍 | 1.20倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ＪＣＲファーマ | 79,700円 | +32.2% | +84.6% | 2.51% | 13.63倍 | 1.77倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
